Barclays’s ATAI Life Sciences ATAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $361K | Sell |
164,887
-77
| -0% | -$169 | ﹤0.01% | 3209 |
|
|
2025
Q1 | $224K | Sell |
164,964
-5
| -0% | -$7 | ﹤0.01% | 3272 |
|
|
2024
Q4 | $219K | Sell |
164,969
-81,581
| -33% | -$108K | ﹤0.01% | 3470 |
|
|
2024
Q3 | $286K | Buy |
246,550
+833
| +0.3% | +$966 | ﹤0.01% | 3307 |
|
|
2024
Q2 | $327K | Hold |
245,717
| – | – | ﹤0.01% | 2774 |
|
|
2024
Q1 | $484K | Hold |
245,717
| – | – | ﹤0.01% | 2855 |
|
|
2023
Q4 | $346K | Sell |
245,717
-22,923
| -9% | -$32.3K | ﹤0.01% | 3222 |
|
|
2023
Q3 | $346K | Sell |
268,640
-6,491
| -2% | -$8.36K | ﹤0.01% | 2749 |
|
|
2023
Q2 | $473K | Buy |
275,131
+22,414
| +9% | +$38.5K | ﹤0.01% | 2630 |
|
|
2023
Q1 | $457K | Buy |
252,717
+163,723
| +184% | +$296K | ﹤0.01% | 2697 |
|
|
2022
Q4 | $236K | Sell |
88,994
-439
| -0.5% | -$1.16K | ﹤0.01% | 3011 |
|
|
2022
Q3 | $295K | Buy |
89,433
+1,601
| +2% | +$5.28K | ﹤0.01% | 2872 |
|
|
2022
Q2 | $319K | Buy |
87,832
+87,755
| +113,968% | +$319K | ﹤0.01% | 2865 |
|
|
2022
Q1 | $0 | Buy |
+77
| New | – | ﹤0.01% | 4755 |
|